| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.05 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |